Nrx Pharmaceuticals Inc (NRXP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NRXP Annual Balance Sheets →
This page allows investors to track Nrx Pharmaceuticals Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent26.69
Cash & Short-term Investments26.00
Accounts receivable0.21
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.46
Total Current Assets29.16
Equipment/Property/Plant Net0.99
Goodwill net1.79
Intangible Assets0.83
Long-term investments0.40
Other Assets, Noncurrent0.99
Subscription Receivable Current-
Operating Lease Right Of Use Asset0.74
Total Assets34.16
Liabilities
Accounts Payable, Current AC3.15
Accrued Liabilities, Current AC0.27
Derivative Liability, Current DE18.55
Loans Payable, Current NO0.41
Other Liabilities, Current11.50
Total Current Liabilities33.87
Total Long-term Debt0.00
Other liabilities, Noncurrent0.46
Accrued Liabilities And Other Current Liabilities11.28
Total Liabilities34.33
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock324.63
Retained Earnings / Accumulated Deficit-324.85
Defined Benefit Plan and Other18.60
Other Equity0.00
Common Stockholder's Equity-0.17
Total Stockholder's Equity-0.17
Liabilities & Stockholder's Equity34.16
4 historic quarters locked

Sign in to unlock the full Nrx Pharmaceuticals Inc balance sheet history.

About Nrx Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-028027

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.